Clinical trial
TBI Dose De-escalation for Fanconi Anemia
NCT00352976 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00352976 |
|---|---|
| Title | TBI Dose De-escalation for Fanconi Anemia |
| Official title | Total Body Irradiation Dose De-escalation Study in Patients With Fanconi Anemia Undergoing Alternate Donor Hematopoietic Cell Transplantation |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Fanconi Anemia |
| Intervention type | Drug, Procedure |
| Interventions | Cyclophosphamide, Fludarabine, Total Body Irradiation, Bone Marrow Transplantation, Mycophenolate Mofetil, Sirolimus |
| Enrollment | 83 |
| Start date | May 18, 2006 |
| Primary completion | Oct 9, 2020 |
| Completion | Oct 9, 2020 |
| First posted | Jul 17, 2006 |
| Last update posted | Nov 24, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: